Flow chemistry validation aimed at improved ARV production

Research-based pharmaceuticals developer iThemba Pharmaceuticals has sent one of its scientists, Dr Darren Riley, to the University of Cambridge to vali- date the use of a new production technique,called continuous flow chemistry, in ultimately producing frontline HIV medicines for South Africa, says iThemba Pharmaceuticals chief scientific officer Dr Chris Edlin.

click here to download full story